|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0023467,
umls-concept:C0030705,
umls-concept:C0332281,
umls-concept:C0600558,
umls-concept:C0871261,
umls-concept:C1442989,
umls-concept:C1704632,
umls-concept:C1706817,
umls-concept:C1882071,
umls-concept:C1979963,
umls-concept:C2003903,
umls-concept:C2911692
|
|
pubmed:issue |
14
|
|
pubmed:dateCreated |
2010-7-16
|
|
pubmed:abstractText |
Complete response to induction chemotherapy is observed in approximately 60% of patients with newly diagnosed non-M3 acute myelogenous leukemia (AML). However, no methods exist to predict with high accuracy at the individual patient level the response to standard AML induction therapy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
1078-0432
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright 2010 AACR.
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
16
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
3721-33
|
|
pubmed:meshHeading |
pubmed-meshheading:20525753-Adult,
pubmed-meshheading:20525753-Aged,
pubmed-meshheading:20525753-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:20525753-Apoptosis,
pubmed-meshheading:20525753-Cohort Studies,
pubmed-meshheading:20525753-Female,
pubmed-meshheading:20525753-Flow Cytometry,
pubmed-meshheading:20525753-Humans,
pubmed-meshheading:20525753-Leukemia, Myeloid, Acute,
pubmed-meshheading:20525753-Male,
pubmed-meshheading:20525753-Middle Aged,
pubmed-meshheading:20525753-Mutation,
pubmed-meshheading:20525753-Predictive Value of Tests,
pubmed-meshheading:20525753-Prospective Studies,
pubmed-meshheading:20525753-Reproducibility of Results,
pubmed-meshheading:20525753-Signal Transduction,
pubmed-meshheading:20525753-Single-Cell Analysis,
pubmed-meshheading:20525753-Young Adult,
pubmed-meshheading:20525753-fms-Like Tyrosine Kinase 3
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Dynamic single-cell network profiles in acute myelogenous leukemia are associated with patient response to standard induction therapy.
|
|
pubmed:affiliation |
Department of Stem Cell Transplantation and Cellular Therapy, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
|
|
pubmed:publicationType |
Journal Article
|
